← Browse by Condition
Medical Condition

artifical intelligence

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for artifical intelligence sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — artifical intelligence Clinical Trials

How many clinical trials are currently recruiting for artifical intelligence?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for artifical intelligence, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for artifical intelligence?
artifical intelligence research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a artifical intelligence clinical trial?
Eligibility criteria for artifical intelligence trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Clinique Rive Gauche 1 trial
Taipei Veterans General Hospital, Taiwan 1 trial
Jena University Hospital 1 trial
The University of Hong Kong 1 trial

Recruiting Clinical Trials

NCT07286591
Recruiting
Study Comparing Two Image Acquisition Modalities for Second-trimester Pregnancy Screening Ultrasound (Echo-IA)
Enrollment
50 pts
Location
France
Sponsor
Clinique Rive Gauche
View Trial →
NCT07562100
Recruiting
Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer
Enrollment
650 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
View Trial →
NCT06765551
Recruiting
AI Based Muscular Ultrasound to Assess Intensive Care Unit-acquired Weakness
Enrollment
50 pts
Location
Germany
Sponsor
Jena University Hospital
View Trial →
NCT07467928
Recruiting
The Long-term Effect of Artificial Intelligence-assisted Colonoscopy on Risk of Metachronous Advanced Colonic Lesion
Enrollment
404 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →

Related Conditions

echography ultrasound (1) oral cancer (1) psychological distress (1) communication aids for disabled (1) physiotherapy (1) return to work (1) prehabilitation (1) physical symptom distress (1) motor function (1) rehabilitation (1) quality of life (1) cost effectiveness (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology